Show simple item record

dc.contributor.authorRobb, Nigel
dc.contributor.authorHarrhy, Claire
dc.description.abstractThe aim of this study, in line with the Rapid Response Report (2008) and current conscious sedation guidance, is to evaluate flumazenil use, reasons for use and to investigate factors which may influence flumazenil use in PWLD having intravenous (IV) sedation with midazolam for dental treatment. The purpose would be to make recommendations to the dental service provider. A retrospective sample of 115 episodes of sedation, comprising of 115 PWLD was selected from patient records to identify level of, and reasons for flumazenil use, as well as factors which may be associated with this. These included: use of premedication; dose of IV midazolam and sedation score, which might be considered as factors which influence flumazenil use. The rate of use of flumazenil was 14.78%.The majority of cases of its use (88%) was due to delayed recovery, 12% were due to difficulty in maintaining satisfactory oxygen saturation (<91%). There were no medical emergencies.
dc.publisherSociety for the Advancement of Anaesthesia in Dentistry; 1999
dc.relation.ispartofjournalSaad Digest
dc.subject.fieldofresearchSpecial Needs Dentistry
dc.titleThe use of flumazenil in a community dental service – a service evaluation
dc.typeJournal article
dc.type.descriptionC2 - Articles (Other)
dcterms.bibliographicCitationRobb, N; Harrhy, C, The use of flumazenil in a community dental service – a service evaluation, Saad Digest, 2019, 35, pp. 28-32
gro.hasfulltextNo Full Text
gro.griffith.authorRobb, Nigel D.

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record